PUBLISHER: DelveInsight | PRODUCT CODE: 1074051
PUBLISHER: DelveInsight | PRODUCT CODE: 1074051
DelveInsight's " Post-traumatic stress disorder (PTSD) - Epidemiology Forecast-2032" report delivers an in-depth understanding of the Post-traumatic stress disorder (PTSD), historical and forecasted epidemiology as well as the Post-traumatic stress disorder (PTSD) trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
Study Period: 2019-2032.
The DelveInsight's Post-traumatic stress disorder (PTSD) epidemiology report gives a thorough understanding of Post-traumatic stress disorder (PTSD) by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. Post-traumatic stress disorder (PTSD) has been described as "the complex somatic, cognitive, affective, and behavioral effects of psychological trauma." It is characterized by intrusive thoughts, nightmares, and flashbacks of past traumatic events, avoidance of reminders of trauma, hypervigilance, and sleep disturbance, all of which lead to considerable social, occupational, and interpersonal dysfunction.
PTSD symptoms may start within 1 month of a traumatic event, but sometimes symptoms may not appear until years after the event. These symptoms cause significant problems in social or work situations and relationships. They can also interfere with the ability to go about the normal daily tasks, and the symptoms are generally grouped into four types: intrusive memories, avoidance, negative changes in thinking and mood, and changes in physical and emotional reactions. Symptoms can vary over time or vary from person to person. Patients can develop PTSD when they go through, see or learn about an event involving actual or threatened death, serious injury, or sexual violation. Several factors can play a role in how people respond to traumatic events. Genetics, for example, can influence how people handle stress during and after a trauma. People may be more likely to develop PTSD if they also have an existing mental health condition, have experienced trauma in the past, face other life stressors, and lack social support.
PTSD is not diagnosed until at least one month has passed since the traumatic event happened. If symptoms of PTSD are present, the doctor will begin an evaluation by performing a complete medical history and physical exam. Although there are no lab tests to diagnose PTSD specifically, the doctor may use various tests to rule out physical illness as the cause of the symptoms. If no physical illness is found, one may be referred to a psychiatrist, psychologist, or other mental health professionals specially trained to diagnose and treat mental illnesses. Psychiatrists and psychologists use specially designed interview and assessment tools to evaluate a person for the presence of PTSD or other psychiatric conditions. The doctor bases their diagnosis of PTSD on reported symptoms, including any problems with functioning caused by the symptoms. The doctor then determines if the symptoms and degree of dysfunction indicate PTSD. PTSD is diagnosed if the person has symptoms of PTSD that last for more than 1 month.
The epidemiology section provides insights about the historical and current Post-traumatic stress disorder (PTSD) patient pool and forecasted trends for individual seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
The disease epidemiology covered in the report provides historical as well as forecasted Post-traumatic stress disorder (PTSD) epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.
In the year 2021, the total diagnosed prevalent cases of Post-traumatic stress disorder (PTSD) was 5,340,957 cases in the 7MM which are expected to grow during the study period, i.e., 2019-2032.
The disease epidemiology covered in the report provides historical as well as forecasted Post-traumatic stress disorder (PTSD) epidemiology [segmented as Prevalent population Cases of PTSD, Diagnosed prevalent cases of PTSD, Gender-specific cases of PTSD, Severity-Specific cases of PTSD, Age-specific cases of PTSD and Total Treated Cases of PTSD] in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2019 to 2032.
The epidemiology segment also provides the Post-traumatic stress disorder (PTSD) epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
To keep up with the current Post-traumatic stress disorder (PTSD) patient pool and forecasted trend, we take KOLs and SMEs ' opinions working in the Post-traumatic stress disorder (PTSD) domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate the patient pool and forecasted trend.